HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines
- PMID: 10602023
- DOI: 10.1002/1521-4141(200001)30:1<19::AID-IMMU19>3.0.CO;2-9
HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines
Abstract
Human macrophage and T cell lines were stably transfected with HIV-1 wild-type Tat or Tat mutants in the cysteine-rich region displaying trans-dominant negative effects on HIV-1 life cycle. The expression of HLA class I and class II molecules was not affected by wild-type Tat. Tat mutants, instead, profoundly down-regulated in a dose-dependent fashion the expression of class II, but not of class I, in both cell types by acting at the transcriptional level. Down-regulation was manifested on constitutive and IFN-gamma-induced class II gene expression and did not correlate with reduced transcription of the AIR-1 gene product CIITA, the major transcriptional activator of class II genes, indicating that Tat mutants did not act by inhibiting AIR-1 gene expression. Class II down-modulation had important functional implications in macrophages, as both antigen processing and presenting capacity were inhibited. These results represent the first evidence that a modified HIV-1 Tat product can act as a potent immunosuppressor by inhibiting the HLA class II expression necessary for triggering both cellular and humoral responses against pathogens. The use of these HIV-1 Tat mutants also discloses new opportunities to investigate the molecular mechanisms underlying the coordinate HLA class II gene transcription.
Similar articles
-
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.J Immunol. 1998 Jul 15;161(2):814-20. J Immunol. 1998. PMID: 9670958
-
Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.Oncogene. 2003 Oct 30;22(49):7848-57. doi: 10.1038/sj.onc.1207054. Oncogene. 2003. PMID: 14586411
-
Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.Biochem Biophys Res Commun. 2000 Dec 20;279(2):494-9. doi: 10.1006/bbrc.2000.3972. Biochem Biophys Res Commun. 2000. PMID: 11118314
-
The role of Tat in HIV-1 replication: an activator and/or a suppressor?AIDS Rev. 2002 Jan-Mar;4(1):41-9. AIDS Rev. 2002. PMID: 11998784 Review.
-
HIV-1 Tat vaccines.Virus Res. 2002 Jan 30;82(1-2):91-101. doi: 10.1016/s0168-1702(01)00393-8. Virus Res. 2002. PMID: 11885958 Review. No abstract available.
Cited by
-
Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes.BMC Microbiol. 2005 Apr 27;5:20. doi: 10.1186/1471-2180-5-20. BMC Microbiol. 2005. PMID: 15857508 Free PMC article.
-
A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10037-41. doi: 10.1073/pnas.152313899. Epub 2002 Jul 2. Proc Natl Acad Sci U S A. 2002. PMID: 12096189 Free PMC article.
-
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.Front Microbiol. 2013 Aug 22;4:234. doi: 10.3389/fmicb.2013.00234. eCollection 2013. Front Microbiol. 2013. PMID: 23986750 Free PMC article.
-
Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.Mol Cell Biol. 2001 Jul;21(14):4626-35. doi: 10.1128/MCB.21.14.4626-4635.2001. Mol Cell Biol. 2001. PMID: 11416140 Free PMC article.
-
Antigen-specific gene expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets.Clin Diagn Lab Immunol. 2004 Sep;11(5):977-82. doi: 10.1128/CDLI.11.5.977-982.2004. Clin Diagn Lab Immunol. 2004. PMID: 15358662 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials